Skip to main content
OpenTrials
Completed

NCT Number: NCT05610449

Assessing Performance of the Testing Done Simple Covid 19 Antigen Test

This study will measure the sensitivity and specificity of the Testing Done Simple severe acute respiratory syndrome (SARS) CoV-2 antigen test in subjects with suspected Covid-19 that present throughout several urgent care clinics. The antigen test performance will be compared to a real-time polymerase chain reaction (RT-PCR) test.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nao Medical Urgent Care-Astoria, Queens, New York, United States

Loading trial locations.

About this study

The Testing Done Simple antigen test is a lateral flow immunoassay that detects the presence of the SARS CoV-2 nucleoprotein and is primarily intended for use in an at home setting. The antigen test will be compared to a traditional RT-PCR tested nasal swab specimens. The purpose of study is to measure the performance of the Testing Done Simple test via sensitivity and specificity when compared to the gold-standard RT-PCR test. The test will be administered in symptomatic and asymptomatic subjects and participants will report the days that has passed since their symptom onset. The RT-PCR test will be performed prior to the Testing Done Simple test.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject was given a SARS CoV 2 PCR test for any of the following 4 reasons:
  • Subject has Covid like symptoms that started within past (7) days
  • Subject has been exposed to another individual with a known Covid diagnosis or probable Covid diagnosis
  • Subject needs Covid test done for travel, school, work, etc
  • Subject works in a high risk environment
  • Subject can provide a nasal swab sample
  • Subject is at least 18 years of age
  • Subject was given a SARS CoV 2 PCR test on same day participating this study
  • Subject provides informed consent

Exclusion criteria

  • Subject is less than 18 years of age
  • Subject does not provide consent
  • Subject's Covid 19 related symptom(s) started greater than 7 days from visit
  • Asymptomatic subjects whom have had symptom(s) within past (14) days
  • Signs of local infection in the area of the face
  • Subject was not given a SARS CoV 2 PCR test on same day as study

Treatment and study plan

Testing Done Simple SARS CoV-2 Antigen Test

Diagnostic Test

Collections of specimens from subjects presenting with Covid-19 like symptoms or known/suspected exposure to SARS CoV-2 via nasal swabs administered by trained medical personnel.

Primary outcomes

  1. Sensitivity

    Time frame: 15 minutes

    Sensitivity (True Positive Rate) of Testing Done Simple Antigen Test compared to RT-PCR

  2. Specificity

    Time frame: 15 minutes

    Specificity (True Negative Rate) of Testing Done Simple Antigen Test compared to RT-PCR

Secondary outcomes

  1. Sensitivity in Relation to the Time Since Symptom Onset in Symptomatic subjects

    Time frame: 15 minutes

    Sensitivity of Testing Done Simple Antigen Test according to the days of symptom onset in symptomatic subjects

Sponsors and collaborators

Lead sponsor

Testing Done Simple

Industry

Collaborators

  • Nao Medical Urgent Care

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Nov 9, 2022
Registry last updated
May 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.